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Abstract
Background: Despite the endemic nature of Echinococcus granulosus and Echinococcus multilocularis infection in regions of
the United States (US), there is a lack of data on echinococcosis-related mortality. To measure echinococcosis-associated
mortality in the US and assess possible racial/ethnic disparities, we reviewed national-death certificate data for an 18-year
period.
Methodology/Principal Findings: Echinococcosis-associated deaths from 1990 through 2007 were identified from multiple-
cause-coded death records and were combined with US census data to calculate mortality rates. A total of 41
echinococcosis-associated deaths occurred over the 18-year study period. Mortality rates were highest in males, Native
Americans, Asians/Pacific Islanders, Hispanics and persons 75 years of age and older. Almost a quarter of fatal
echinococcosis-related cases occurred in residents of California. Foreign-born persons accounted for the majority of
echinococcosis-related deaths; however, both of the fatalities in Native Americans and almost half of the deaths in whites
were among US-born individuals.
Conclusions/Significance: Although uncommon, echinococcosis-related deaths occur in the US. Clinicians should be aware
of the diagnosis, particularly in foreign-born patients from Echinococcus endemic areas, and should consider tropical
infectious disease consultation early.
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Introduction
Human echinococcosis, a neglected disease caused by the larval
stages of the cestode parasites Echinococcus granulosus (hydatid cyst
disease) and E. multilocularis (alveolar hydatid disease), affects an
estimated 2–3 million people and results in an annual monetary
loss of over $750,000,000 worldwide [1,2]. The infection is a
zoonosis, normally maintained in dogs and sheep in close
association with humans (E. granulosus), or in a wild cycle, such
as in foxes or wild canines and rodents (E. multilocularis). Humans
are an aberrant intermediate host for the disease, developing life-
threatening tissue cysts, predominately in the liver and lung,
following accidental ingestion of eggs in infected dog, fox and wild
canine feces. Once a human is infected, treatment is complicated
and carries significant risks. Approaches include the use of
antihelmintic drugs, surgery, and/or medico-surgical procedures
such as PAIR (puncture, aspirate, injection of a scolicide, re-
aspirate) [3].
Hydatid cyst disease, accounting for over 95% of human
echinococcosis, predominates in poor, pastoral communities that
raise sheep and other livestock, and keep dogs for guarding and
herding because of the complex two-host lifecycle [4]. Although
alveolar hydatid disease is less common in humans, it is more
pathogenic, more difficult to treat, and has a higher mortality than
cystic hydatid disease. Although the majority of the disease burden
is located outside of the United States, both E. granulosus and E.
multilocularis are endemic to regions of the United States [5–9]. E.
granulosus (senso stricto or G1 strain) has been recorded in a few
foci such as certain communities in Utah and California and E.
granulosus (G8 or G10 strains) is more common in Alaska than the
lower 48 states. E. multilocularis is endemic in wildlife across much
of the mid-western United States and Alaska. In the United States,
human echinococcosis is not a nationally notifiable infectious
condition [10].
Despite the occurrence of human echinococcosis in the
United States and its potential for causing fatal disease, there is
a lack of information about echinococcosis-related deaths in the
United States. Information on echinococcosis mortality is
important to better understand the burden of disease and
evaluate the effectiveness of public health interventions.
Population-based mortality data has been used to investigate
other infectious diseases, but these data have not yet been used
in published echinococcosis research. We examined national
mortality data to assess the burden and demographics of
echinococcosis-related mortality in the United States from 1990
to 2007.
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De-identified, publicly available multiple-cause-of-death data
from US death certificates from the National Center for Health
Statistics (NCHS) were analyzed for the years 1990–2007 [11].
These death certificates contain basic demographic information
for each decedent, including age, sex, race/ethnicity, and state of
residence. In addition to designating underlying causes, the
physician or coroner completing the death certificate may list up
to 20 conditions that are believed to have contributed in some way
to the death of an individual. Each of these conditions is coded on
the basis of the International Classification of Diseases (ICD) system for
the year in which the death occurred (ICD, Ninth Revision [ICD-9]
for the period 1990–1998 and ICD, Tenth Revision [ICD-10] for the
period 1999–2007).
We defined echinococcosis-related cases as US resident deaths
having an ICD-9 code of 122.0–122.9 or an ICD-10 code of
B67.0–B67.9 listed as an underlying or contributing cause on the
death record.
Mortality rates and 95% confidence intervals (CIs) were
calculated using bridged-race population estimates derived from
US census data and were subsequently age-adjusted with weights
from the 2000 US standard population data. Mortality rates for
race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic,
Asian/Pacific Islander, and Native American), sex, age, year, and
state were calculated with aggregated data from all years of our
study to ensure stable rates. All calculations were performed with
SAS software, version 9.2.
Results
We identified 41 echinococcosis-related deaths among US
residents during the period 1990–2007 (Table 1). Age-adjusted
mortality rates were higher in males (0.012 per 10
6) than in
females (0.005 per 10
6), with males more than 2 times as likely to
die from echinococcosis than were females (adjusted rate
ratio=2.2, 95% CI 1.3–3.9). Native Americans (0.062 per 10
6),
Asian/Pacific Islanders (0.032 per 10
6), and Hispanics (0.014 per
10
6) had the highest age-adjusted echinococcosis mortality rates,
with adjusted rate ratios of 8.9 (95% CI 6.1–12.9), 4.6 (95% CI
3.2–6.7), and 1.9 (95% CI 1.3–2.9), respectively, compared to
whites. No echinococcosis-related deaths were recorded in non-
Hispanic blacks. The majority of echinococcosis-related deaths
(35, 85%) occurred in persons over 35 years of age, with the
highest rates noted in persons 85+ years. Echinococcus species was
unspecified in 36 (88%) cases and was identified as E. granulosus
and E. multilocularis in 3 (7%) and 2 (5%) cases, respectively. Site of
infection was unspecified in 23 cases (56%), infection of liver and
lung were recorded in 17 (42%) and 1 (2%) cases, respectively.
Echinococcosis-related deaths fluctuated throughout the 18-year
study period, ranging from 0–5 deaths annually, with 26 (63%)
and 15 (37%) cases reported in the first and second halves of the
study period, respectively. Twenty-three states reported echino-
coccosis-related fatalities, with California (9, 22%) having the
highest number of deaths. A majority of echinococcosis-related
deaths (30, 73%) occurred in foreign-born persons. Mean age at
death differed slightly between foreign-born (57.9) and U.S.-born
persons (64.5), and gender differences were observed (70% and
45% males, respectively).
Discussion
Although uncommon, fatal echinococcosis occurs in US
residents and disproportionally affects selected demographic
groups. Mortality rates were highest in males, Native Americans,
Asians/Pacific Islanders, Hispanics, and persons 75 years of age
and older. There was a weak declining temporal trend over the
study period, and almost a quarter of all echinococcosis-related
deaths occurred in residents of California. Foreign-born persons
accounted for the majority of echinococcosis-related deaths;
however, almost half of deaths in whites and both deaths in
Native Americans were among US-born individuals.
The apparent increased risk of echinococcosis-related mortality
in males may reflect higher rates of occupational exposures from
the tending of livestock. The increased mortality risk in Asians/
Pacific Islanders and Hispanics, all of whom were foreign born,
presumably reflects greater exposure to Echinococcus species in their
country of origin prior to emigration and upon return trips to visit
friends and relatives. The observed increased risk of echinococ-
cosis in persons over 75 years of age may be a result of increased
prevalence of comorbid diseases and declining immune function.
The higher number of echinococcosis-related deaths in California
is expected, given the large population and sizable number of
immigrants from Latin America and Asia.
Liver was the most common reported site of infection, which is
expected, as liver involvement is the most common manifestation
of echinococcosis. Incomplete information and lack of sufficient
numbers precluded an assessment of possible associations between
demographic factors and site of infection.
The occurrence of echinococcosis-related deaths in US-born
persons reflects either local Echinococcus species transmission or
travel-related infection. Because death certificates do not have
information on travel, we are unable to determine whether US-
born decedents acquired infections domestically or abroad.
Several important limitations are associated with the use of
multiple-cause-of-death data that require consideration. Although
these data are population based and contain large numbers of
observations, death certificates likely underreport causes of death
and may contain errors, which have been attributed to a variety of
factors [12]. Mortality rates may be distorted because of errors in
population estimates, particularly for race/ethnicity. Because
estimates of the at-risk population factor into the denominator
for rate calculations, such errors can lead to biased estimates. In
addition, the small number of echinococcosis-related deaths and
the lack of species-specific information make interpretation
difficult. Finally, although inferential statistics are not designed
Author Summary
Human echinococcosis is a parasitic disease that affects an
estimated 2–3 million people and results in an annual
monetary loss of over $750,000,000 worldwide. It results in
the development of life threatening tissue cysts, primarily
in the liver and lung, following accidental ingestion of
eggs in infected dog, fox or wild canine feces. Echinococcus
parasites have a complex, two-host lifecycle (such as in
dogs and sheep) in which humans are an aberrant, dead-
end host. The vast majority of cases of human echinococ-
cosis occur outside of the United States (US); however,
cases within the US do occur. In this study, the authors
examined death certificate data of US residents from
1990–2007 in which echinococcosis was listed as one of
the diagnoses at death. The analysis demonstrated 41
echinococcosis-related deaths over the 18-year study
period with foreign-born persons accounting for the
majority of the deaths. This study helps quantify echino-
coccosis deaths among US residents and adds further
support to the importance of funding echinococcosis
prevention research.
U.S. Echinococcosis Mortality, 1990–2007
www.plosntds.org 2 February 2012 | Volume 6 | Issue 2 | e1524for use with population-based data, we have used such methods to
demonstrate that error does exist. We urge caution in the strict
interpretation of our values.
Fatal echinococcosis may be more common in the United States
than currently appreciated. Echinococcosis causes a mortality
burden in the United States that may be modified by increased
prevention and control efforts, including vaccine development for
adult cestode carriers and livestock [13]. Given the presence of
echinococcosis mortality in US-born persons, and the risk of
travel-related exposure, hygiene precautions should be advised for
individuals traveling to Echinococcus species endemic areas.
Clinicians should be aware of the diagnosis, particularly in
Table 1. Echinococcosis-related deaths, adjusted mortality rates and rate ratios, United States, 1990–2007.
Variable No. of deaths
Age-adjusted* mortality rate per
1,000,000 person years (95% CI) Rate Ratio (95% CI)
All echinococcosis-related deaths 41 0.008 (0.006–0.011)
Sex
Male 26 0.012 (0.007–0.017) 2.2 (1.3–3.9)
Female 15 0.005 (0.003–0.008) referent group
Race
Non-Hispanic white 28 0.007 (0.004–0.010) referent group
Hispanic 7 0.014 (0.002–0.025) 1.9 (1.3–2.9)
Asian/Pacific Islander 4 0.032 (0.000–0.067) 4.6 (3.2–6.7)
Native American 2 0.062 (0.000–0.154) 8.9 (6.1–12.9)
Non-Hispanic black 0
Year
1990 5 0.021 (0.002–0.039)
1991 2 0.008 (0.000–0.020)
1992 3 0.013 (0.000–0.028)
1993 2 0.009 (0.000–0.021)
1994 5 0.020 (0.002–0.038)
1995 5 0.019 (0.002–0.035)
1996 4 0.016 (0.000–0.032)
1997 0
1998 0
1999 2 0.007 (0.000–0.018)
2000 2 0.007 (0.000–0.017)
2001 2 0.007 (0.000–0.017)
2002 5 0.018 (0.002–0.033)
2003 1 0.003 (0.000–0.010)
2004 1 0.004 (0.000–0.011)
2005 0
2006 1 0.003 (0.000–0.009)




5–14 1 0.001 (0.000–0.004)
15–24 4 0.006 (0.000–0.011)
25–34 1 0.001 (0.000–0.004)
35–44 6 0.004 (0.001–0.007)
45–54 2 0.003 (0.000–0.007)
55–64 10 0.022 (0.009–0.036)
65–74 5 0.015 (0.002–0.028)
75–84 5 0.023 (0.003–0.044)
85+ 7 0.094 (0.024–0.016)
*- for sex, race, and year.
doi:10.1371/journal.pntd.0001524.t001
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